These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7935665)

  • 1. Fish oil for IgA nephropathy?
    van Ypersele de Strihou C
    N Engl J Med; 1994 Nov; 331(18):1227-9. PubMed ID: 7935665
    [No Abstract]   [Full Text] [Related]  

  • 2. Fish oil therapy in IgA nephropathy.
    Fung SM; Ferrill MJ; Norton LL
    Ann Pharmacother; 1997 Jan; 31(1):112-5. PubMed ID: 8997477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fish oil to treat patients with immunoglobulin a nephropathy.
    Donadio JV
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):373S-5S. PubMed ID: 10618000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in treatment: immunoglobulin A nephropathy.
    Hogg RJ; Waldo B
    Semin Nephrol; 1996 Nov; 16(6):511-6. PubMed ID: 9125795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin A nephropathy: fish oils and beyond.
    Feehally J
    Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):442-6. PubMed ID: 8937814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy.
    Wardle EN
    N Engl J Med; 2003 Jan; 348(1):79-81; author reply 79-81. PubMed ID: 12510692
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of patients with IgA-nephropathy: a critical appraisal.
    Floege J; Mertens P
    Kidney Blood Press Res; 2000; 23(3-5):207-9. PubMed ID: 11031723
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of IgA nephropathy: status at the end of the millenium.
    Glassock RJ
    J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy treatment 25 years on: can we halt progression? The evidence base.
    Ballardie FW
    Nephrol Dial Transplant; 2004 May; 19(5):1041-6. PubMed ID: 15102965
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of dietary fish oil supplementation in IgA nephropathy. Mechanistic implications.
    Grande JP; Donadio JV
    Minerva Urol Nefrol; 2001 Dec; 53(4):201-9. PubMed ID: 11753248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fish oil in a patient with post-transplantation IgA nephropathy.
    Butani L; Palmer J
    Nephrol Dial Transplant; 2000 Aug; 15(8):1264-5. PubMed ID: 10910466
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment options for IgA nephropathy in adults: a proposal for evidence-based strategy.
    Laville M; Alamartine E
    Nephrol Dial Transplant; 2004 Aug; 19(8):1947-51. PubMed ID: 15161954
    [No Abstract]   [Full Text] [Related]  

  • 14. New therapeutic approaches in primary IgA nephropathy.
    Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Bolasco P; Fogazzi G; Altieri P; Ponticelli C
    Adv Nephrol Necker Hosp; 1999; 29():73-91. PubMed ID: 10561738
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evidence of therapy of IgA nephropathy].
    Gan WH; Zhang AQ; Ding GX; Gong J
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):101-3. PubMed ID: 17448301
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group.
    Donadio JV; Bergstralh EJ; Offord KP; Holley KE; Spencer DC
    Clin Nephrol; 1994 Feb; 41(2):65-71. PubMed ID: 8004831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating IgA nephropathy.
    Dillon JJ
    J Am Soc Nephrol; 2001 Apr; 12(4):846-847. PubMed ID: 11274247
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of IgA nephropathies: a critical viewpoint].
    Mertens PR; Floege J
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1010. PubMed ID: 11004914
    [No Abstract]   [Full Text] [Related]  

  • 19. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F; Vecchio LD; Pozzi C
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability.
    Dillon JJ
    J Am Soc Nephrol; 1997 Nov; 8(11):1739-44. PubMed ID: 9355077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.